http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5948498-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c9446a65422eaca792040fe2b817fb5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
filingDate 1982-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e9cb955c46e6def626e0bea0959a91a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb33e3a39e7f569e012c33efcb97bac4
publicationDate 1984-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5948498-A
titleOfInvention 1-beta-d-arabinofuranosylcytosine-5'-phosphoric acid derivative
abstract NEW MATERIAL:A compound (salt) shown by the formula I (R is bifunctional aliphatic hydrocarbon). n EXAMPLE: 1-β-D-Arabinofuranosylcytosine-5'-(2-hydroxyethyl)phosphoric acid. n USE: An antitumor agent, and an intermediate for synthesizing drugs. n PROCESS: For example, 1-β-D-arabinofuranosylcytosine-5'-phosphoric acid is condensed with a dihydric alcohol (e.g., ethylene glycol, etc.) having a hydrocarbon residue corresponding to a bifunctional hydrocarbon residue to the desired compound in an organic solvent such as pyridine, etc. using a condensation agent such as an arylsulfonyl chloride (e.g., triisopropylbenzenesulfonyl chloride, etc.). n COPYRIGHT: (C)1984,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008516176-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0351904-U
priorityDate 1982-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S55129299-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227942569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID237555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11514985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53765124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236262824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13369307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226570717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049

Total number of triples: 38.